We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tübingen High Altitude Ophthalmology Study (THAO)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01245114
First Posted: November 22, 2010
Last Update Posted: December 3, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital Tuebingen
  Purpose
Tuebingen High Altitude Ophthalmology Study to investigate the effects of high altitude on retinal structure and function as well as anterior chamber in regard to acute mountain sickness.

Condition
Altitude Hypoxia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Tübingen High Altitude Ophthalmology Study (THAO)

Further study details as provided by University Hospital Tuebingen:

Study Completion Date: December 2010
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
healthy volunteers
Criteria

Inclusion Criteria:

  • healthy subjects, non-smokers, physical fitness,

Exclusion Criteria:

  • ocular pathologies, ascent above 2000m 2 weeks prior to study and 2 weeks before post-examination
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01245114


Locations
Germany
Eye Hospital, University of Tübingen
Tübingen, BW, Germany, 72076
Sponsors and Collaborators
University Hospital Tuebingen
Investigators
Study Director: Florian Gekeler, MD Eye Hospital, University of Tübingen, Germany
Principal Investigator: Gabriel Willmann, MD Eye Hospital, University of Tübingen, Germany
  More Information

Responsible Party: Prof. Florian Gekeler, Eye Hospital, University Hospital Tübingen, Germany
ClinicalTrials.gov Identifier: NCT01245114     History of Changes
Other Study ID Numbers: THAO
First Submitted: November 19, 2010
First Posted: November 22, 2010
Last Update Posted: December 3, 2010
Last Verified: July 2010

Additional relevant MeSH terms:
Hypoxia
Signs and Symptoms, Respiratory
Signs and Symptoms